As of 2026-10-25, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 1.65 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.93 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is -66.5%.
The range of the Relative Valuation is 1.11 - 2.54 CAD.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 27.4x | 17.9x |
| Forward P/E multiples | 14.7x - 23.4x | 17.9x |
| Fair Price | 1.11 - 2.54 | 1.65 |
| Upside | -77.4% - -48.4% | -66.5% |
| Date | P/E |
| 2026-10-22 | 65.33 |
| 2026-10-21 | 65.86 |
| 2026-10-20 | 65.07 |
| 2026-10-19 | 64.14 |
| 2026-10-16 | 64.80 |
| 2026-10-15 | 63.61 |
| 2026-10-14 | 63.87 |
| 2026-10-13 | 63.74 |
| 2026-10-09 | 65.46 |
| 2026-10-08 | 65.99 |
| 2026-10-07 | 64.40 |
| 2026-10-06 | 63.87 |
| 2026-10-05 | 64.80 |
| 2026-10-02 | 62.42 |
| 2026-10-01 | 65.07 |
| 2026-09-30 | 66.12 |
| 2026-09-29 | 66.12 |
| 2026-09-28 | 67.71 |
| 2026-09-25 | 67.71 |
| 2026-09-24 | 66.65 |
| 2026-09-23 | 67.05 |
| 2026-09-22 | 68.64 |
| 2026-09-21 | 67.31 |
| 2026-09-18 | 66.78 |
| 2026-09-17 | 66.52 |
| 2026-09-16 | 66.12 |
| 2026-09-15 | 65.20 |
| 2026-09-14 | 66.26 |
| 2026-09-11 | 67.18 |
| 2026-09-10 | 66.26 |
| 2026-09-09 | 67.18 |
| 2026-09-08 | 67.18 |
| 2026-09-04 | 66.92 |
| 2026-09-03 | 67.45 |
| 2026-09-02 | 69.16 |
| 2026-09-01 | 69.16 |
| 2026-08-31 | 69.30 |
| 2026-08-28 | 66.92 |
| 2026-08-27 | 67.84 |
| 2026-08-26 | 68.50 |
| 2026-08-25 | 68.11 |
| 2026-08-24 | 68.37 |
| 2026-08-21 | 67.97 |
| 2026-08-20 | 66.26 |
| 2026-08-19 | 67.05 |
| 2026-08-18 | 68.11 |
| 2026-08-17 | 69.30 |
| 2026-08-14 | 70.62 |
| 2026-08-13 | 72.07 |
| 2026-08-12 | 71.02 |